As the U.S. Senate Committee on Agriculture, Nutrition, and Forestry concludes today's hearing, "Perspectives on the ...
Following alignment discussions with FDA, BLA completion for HR BCG-unresponsive NMIBC is expected fourth quarter 2026 PIVOT-006 Phase 3 topline ...
Pivot Bio announced the expansion of its Greater St. Louis footprint with two new Centers of Excellence anchored in Hazelwood and Creve Coeur.
XTL Biopharmaceuticals (NASDAQ:XTLB) announced an acquisition of Psyga Bio, a move that could reposition the company within ...
A development scientist at Pivot Bio works with spectrometer to measure acetylene reduction activity in a plant sample. (Image courtesy of Pivot Bio) This week, Pivot Bio debuted two new centers in ...
This week, Pivot Bio debuted two new centers in the St. Louis area that are intended to accelerate its crop nutrition innovation and U.S. manufacturing capabilities. These two “Centers of Excellence,” ...
Hazelwood just scored a big win in the agtech game, with Pivot Bio announcing Tuesday that it will expand into the north St. Louis County city, invest more than $7 million and create 40 new jobs as it ...
The company plans to relocate its manufacturing and innovation center to the St. Louis area to pair with its research and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An agtech company, which ...
As fertilizer markets continue to face significant volatility driven by global supply pressures, energy dynamics and geopolitical uncertainty, one of the world’s most innovative ag tech companies, ...
Pivot Bio CEO Chris Abbott talks about the company's investment in to the St. Louis region at its Hazelwood facility on April 28, 2026. The company is making a $7 million incremental investment in the ...
Company’s growing presence in Missouri will accelerate crop nutrition innovation and U.S. manufacturing capabilities As fertilizer markets continue to face significant volatility driven by global ...